IL1B and coronary artery disorder: Dysregulation of cell metabolism can lead to diseases like cancer, CVDs, and metabolic disorders.605,606 In CAD patients’ monocytes and macrophages, excessive glucose metabolism enhances IL-6 and IL-1β production through mitochondrial ROS and nuclear PKM2, driving systemic inflammation.